From: PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
PD-L1 (%) | Total | |||||
---|---|---|---|---|---|---|
0 | 1–9 | 10–49 | ≥50 | P = 0.09 | ||
TIL | Negative (0) | 34 (62.9%) | 1 (33.3%) | 4 (44.4%) | 0 | 39 (58.2%) |
Low (1–9) | 13 (24.1%) | 2 (66.7%) | 1 (11.1%) | 0 | 16 (23.9%) | |
Intermediate (10–59) | 6 (11.1%) | 0 | 4 (44.4%) | 1 (100%) | 11 (16.4%) | |
High (≥60) | 1 (1.9%) | 0 | 0 | 0 | 1 (1.5%) | |
54 (80.6%) | 3 (4.5%) | 9 (13.4%) | 1 (1.5%) |